US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.710
  • +0.340+24.82%
Close Dec 3 16:00 ET
  • 1.680
  • -0.030-1.75%
Post 20:01 ET
197.01MMarket Cap-19000P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Coherus BioSciences Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
56.81M
70.77M
+13.97M
Beat Est.
-23.82%
-5.09%
+24.59%
EPS
-0.26
-0.09
+0.17
Beat Est.
+36.72%
+78.05%
+65.30%
Analyst Rating
Strong Buy

Nov 30, 2024

Coherus BioSciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 66.550M--
--2024/Q4-- / 43.877M--
Nov 6, 20242024/Q370.774M / 56.806M--
Aug 8, 20242024/Q264.979M / 56.423M--
May 9, 20242024/Q177.063M / 83.747M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 66.550M--
--2024/Q4-- / 43.877M--
Nov 6, 20242024/Q370.774M / 56.806M--
Aug 8, 20242024/Q264.979M / 56.423M--
May 9, 20242024/Q177.063M / 83.747M--

Unlock Free Earnings Estimates

Coherus BioSciences Earnings Reports

  • Coherus BioSciences | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:39 ET

  • Coherus BioSciences | 8-K: Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 6 16:29 ET

  • Coherus BioSciences | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:45 ET

  • Coherus BioSciences | 8-K: Coherus BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 8 16:40 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.87%